VOR
Vor Biopharma·NASDAQ
--
--(--)
--
--(--)
3.84 / 10
Netural
Analyst consensus is overwhelmingly bullish (Buy 100%), though only one recent rating exists. Fund‑flow metrics are strong, with overall, block and extra‑large inflows positive, while small, medium and large categories show outflows. Sentiment score is solid, yet the mixed picture calls for prudence.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-19
InstitutionWells Fargo
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of VOR?
- VOR holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.84/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
